References
- Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., De Wolf-Peters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H-K., Pileri S. A., Piris M. A., Ralfkier E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1984; 84: 1361–1392
- The Non-Hodgkin's Lymphoma Classification Project. Effect on age and clinical behavior of non-Hodgkin's lymphoma patients. Ann Oncol 1997; 8: 973–78
- The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
- Cartwright R., Brincker H., Carli P. M., Clayden D., Coebergh J. W., Jack A., McNally R., Morgan G., de Sanjose S., Tumino R., Vomanen M. The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer 1999; 35: 627–633
- Stansfeld A., Diebold J., Kapanci Y., Kelényi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., van Unnik J. A.M., Wright D. H. Updated Kiel classification for lymphomas. Lancer 1988; 1: 292–293
- Lennert K., Feller A. C. Histopathology of Non-Hodgkin's Lymphomas. Springer Verlag, Berlin 1992
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
- Pittaluga S., Bijnens L., Teodorovic I., Hagenbeek A., Meerwaldt J. H., Somers R., Thomas J., Noordijk E. M., de Wolf-Peelers C. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group sub-typed according to the revised European-American classification of lymphoid neoplasms: A comparison with the Working Formulation. Blood 1996; 87: 4358–4367
- Anderson J. R., Armitage J. O., Weisenburger D. D. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hogkin's Lymphoma Classification Project. Ann Oncol 1998; 9: 717–720
- Salar A., Fernández de Sevilla A., Romagosa V., Domingo-Claros A., González-Barca E., de Sanjosé S., Pera J., Servitje O., Grañena A. Distribution and incidence rates of lymphoid neoplasms according to the REAL classification in a single institution. A prospective study of 940 cases. Eur J Hematol 1997; 59: 231–237
- Paryani S. B., Hoppe R. T., Cox R. S., Colby T V., Kaplan H. S. The role of radiation therapy in the management of stage III follicular lymphomas. J Clin Oncol 1984; 2: 841–848
- Geisler C. H., Larsen J. K., Hansen N. E., Hansen M. M., Christensen B. E., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., Andersen P. K. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with chronic lymphocytic leukemia. Blood 1991; 1991(78)1795–1802
- Dimopoulos M. A., Panayiotidis P., Moulopoulos L. A., Sfikakis P., Dalakas M. Waldenström's macroglobulinemia: Clinical features. Complications, and management. J Clin Oncol 2000; 18: 214–226
- Kwak L., Wilson M., Weiss L., Homing S., Warnke R., Dorfman R. Clinical significance of morphologic subdivision in diffuse large cell lymphoma. Cancer 1991; 68: 1988–1993
- Rabkin C. S., Devesa S. S., Zahm S. H., Gail M. H. Increasing incidence of non-Hodkin's lymphomas. Semin Hematol 1993; 30: 286–296
- Martinsson U., Glimelius B., Sundström C. Lymphoma incidence in a Swedish county during 1969–1987. Acta Oncol 1902; 31: 275–282